Immediate Impact
13 standout
Citing Papers
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of Katrin Conen being referenced
MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial
2020
OS07.2 Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the ARTE trial
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Katrin Conen | 21 | 37 | 9 | 46 | 38 | 22 | 140 | |
| Mindy X. Wang | 19 | 15 | 4 | 14 | 34 | 23 | 162 | |
| Sarah Tang | 13 | 15 | 8 | 32 | 39 | 17 | 182 | |
| Milena La Spina | 21 | 26 | 3 | 12 | 21 | 23 | 173 | |
| Virginia Noxon | 17 | 12 | 11 | 34 | 14 | 31 | 156 | |
| Luisa Savoldi | 11 | 8 | 2 | 88 | 36 | 23 | 159 | |
| Mohammed Alkhalifah | 19 | 18 | 2 | 43 | 5 | 24 | 135 | |
| Catriona Keerie | 15 | 10 | 6 | 29 | 16 | 20 | 144 | |
| T. De Greslan | 10 | 40 | 1 | 71 | 53 | 25 | 181 | |
| Brian C. Boulmay | 12 | 8 | 7 | 51 | 36 | 27 | 118 | |
| Priya Sriskandarajah | 11 | 25 | 2 | 40 | 27 | 18 | 142 |
All Works
Login with ORCID to disown or claim papers
Loading papers...